Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Almouneer operates a commercial digital health platform focused on the Middle East and Africa. Its DRU app enables patients with diabetes, prediabetes, obesity, or related ophthalmic conditions to manage their care digitally—uploading medical records, tracking vital metrics like blood sugar/blood pressure, accessing teleconsultations with doctors/health coaches/nutritionists/labs—and receive personalized treatment plans. The company has partnered with leading regional hospitals such as the International Medical Center in Egypt to expand its reach. It serves over 120,000 patients across nine hospitals/clinics in Egypt and is expanding into Saudi Arabia, UAE, Nigeria, Kenya.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Almouneer.